Like many companies, when we launched our strategic plan in January, we had no idea what the year would hold. We will remember 2020 not only as a year of unprecedented challenges, but of resilience and innovation. In this post, we’ll cover some of the milestones that made this a truly monumental year for LuminUltra…. Read More
Over the course of the COVID-19 pandemic, it is likely that many people have forgotten about Legionella, which has been described as a “quiet pandemic” by legislators in the United States. While the focus of many government health authorities has been to react to and reduce the impact of COVID-19, the many stay at home… Read More
The phrase “back-to-school” brings to mind fresh notebooks, new teachers, and friends. This fall, in the midst of the COVID-19 pandemic, it’s filled with uncertainty and anxiety. Teachers are concerned about returning to the classroom, with 2 out of 3 preferring the idea of teaching online. Students are thinking less about the clubs they’ll join… Read More
LuminUltra Technologies Ltd. is proud to announce that we’ve submitted our GeneCount® COVID-19 RT-qPCR Assay Kit to the U.S. Food and Drug Administration for Emergency Use Authorization and Health Canada for an Interim Order. With this authorization we’ll be able to provide testing facilities throughout North America with a complete, customizable clinical COVID-19 testing solution…. Read More
Environmental surveillance testing is an important tool to re-open the healthcare industry and keep it open. Learn about its benefits.
New details about SARS-CoV-2, the virus that causes COVID-19, seem to emerge daily. Expanded Testing Requirements A concerning but important finding is that viable virus can be recovered from pre-symptomatic individuals several days before symptoms appear – as well as from asymptomatic individuals. This highlights the need for effective surveillance and contact tracing programs, which include identifying and testing asymptomatic and pre-symptomatic individuals, to prevent further spread. While contact tracing will always require clinical testing for those who’ve… Read More
While much of the COVID-19 response to date has been focused on human-to-human transmission of the virus, largely unaddressed to date are the ongoing risks of environmental transmission and the role of environmental monitoring to understand the health of both facilities and people. What is environmental monitoring? Many will be familiar now with the human testing protocol employed by most countries around the… Read More
Note from the Author: This white paper resulted from a collaboration between LuminUltra, IWC Environmental Solutions, and Source Molecular. SARS-CoV-2, the virus which causes COVID-19, is highly contagious and has been shown to remain viable on surfaces for several days after exposure depending on the surface material. This is particularly alarming as the asymptomatic infection rate has… Read More
Familiarity with the results is important Since many operators like to have results reported in a format that is familiar to them, it is possible to convert the gene copies/mL obtained from a qPCR reaction into an approximate cells/mL which is a calculation based on the average amount of gene copies per organism determined from… Read More
qPCR with quick and easy-to-interpret results will be key As quantitative Polymerase Chain Reaction (qPCR) becomes more accepted and available to a range of industries looking to quantify their (specific) microbial populations, the ability to provide quick and easy-to-interpret results will be key. The initial development of qPCR assays has been focused on potential human… Read More
Update your browser to view this website correctly. Update my browser now
